PDCD1 and cancer: In the latent tuberculosis group, none of these patients developed active tuberculosis after anti-PD-(L)1 therapy, which was in line with another retrospective study in which none of the anti-PD-1 regimen treated cancer patients with positive IGRA testing developed active tuberculosis [17].